Literature DB >> 29972676

Gold nanoparticles as tracking devices to shed light on the role of caveolin-1 in early stages of melanoma metastasis.

Simón Guerrero1,2,3, Victor Manuel Díaz-García1,2,3,4, Pamela Contreras-Orellana1,2,3, Pablo Lara1,2,3,5, Sujey Palma1,2,3,5, Fanny Guzman6, Lorena Lobos-Gonzalez1,2,3,7, Areli Cárdenas1,3,8, Ximena Rojas-Silva9, Luis Muñoz9, Lisette Leyton1,2,3, Marcelo J Kogan3,5, Andrew Fg Quest1,2,3.   

Abstract

AIM: To track early events during lung metastasis, we labeled cells expressing (B16F10CAV1) or lacking CAV1 (B16F10mock) with gold nanoparticles conjugated to the peptide TAT (AuNPs-PEG-TAT).
METHODS: B16F10 expressing or lacking CAV1 were labeled with AuNPs-PEG-TAT. The physicochemical properties and cytotoxicity of these nanoparticles, as well as their effects on migration and invasiveness of B16F10 cells in vitro were evaluated. Ex vivo lung distribution of the labeled cells after tail vein injection into C57BL/6 mice was examined.
RESULTS: AuNPs-PEG-TAT did not affect B16F10 viability, migration and invasiveness. The metastatic and tumorigenic capability of the labeled B16F10 was also not modified in comparison to unlabeled B16F10 cells. CAV1 expression favored the retention of B16F10 cells in the lungs of mice 2 h post injection, suggesting CAV1 promoted adherence to endothelial cells and transendothelial migration.
CONCLUSIONS: We developed a protocol to label B16F10 cells with AuNPs-PEG-TAT that permits subsequent tracking of cells in mice. CAV1 overexpression was found to increase retention and transendothelial migration of B16F10 cells in the lung.

Entities:  

Keywords:  cell labeling; cell tracking; gold nanoparticles; metastasis; theranostics

Mesh:

Substances:

Year:  2018        PMID: 29972676     DOI: 10.2217/nnm-2017-0390

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  2 in total

Review 1.  The importance of caveolins and caveolae to dermatology: Lessons from the caves and beyond.

Authors:  Andjela N Egger; Ali Rajabiestarabadi; Natalie M Williams; Sydney R Resnik; Joshua D Fox; Lulu L Wong; Ivan Jozic
Journal:  Exp Dermatol       Date:  2020-01-10       Impact factor: 3.960

2.  The RabGEF ALS2 is a hypoxia inducible target associated with the acquisition of aggressive traits in tumor cells.

Authors:  Solange Rivas; Patricio Silva; Montserrat Reyes; Hugo Sepúlveda; Luis Solano; Juan Acuña; Marisol Guerrero; Manuel Varas-Godoy; Andrew F G Quest; Martín Montecino; Vicente A Torres
Journal:  Sci Rep       Date:  2020-12-18       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.